New Antimicrobial Options in the Clinical Practice of Infections Caused by Difficult-to-Treat Pathogens: A Global Opportunity for Public Health
Antimicrobial resistance (AMR) is a serious cause of concern for public health [...]
Saved in:
Main Author: | Luigi Principe (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current and Potential Therapeutic Options for Infections Caused by Difficult-to-Treat and Pandrug Resistant Gram-Negative Bacteria in Critically Ill Patients
by: Helen Giamarellou, et al.
Published: (2022) -
Superinfection with Difficult-to-Treat Pathogens Significantly Reduces the Outcome of Periprosthetic Joint Infections
by: Ali Darwich, et al.
Published: (2021) -
Treatment options for refractory and difficult to treat seizures: focus on vigabatrin
by: Tolman JA, et al.
Published: (2011) -
Trends of Multidrug-Resistant Pathogens, Difficult to Treat Bloodstream Infections, and Antimicrobial Consumption at a Tertiary Care Center in Lebanon from 2015-2020: COVID-19 Aftermath
by: Amanda Chamieh, et al.
Published: (2021) -
The Burden of the Serious and Difficult-to-Treat Infections and a New Antibiotic Available: Cefiderocol
by: Yasaman Taheri, et al.
Published: (2021)